AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22800982 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain global rating of change measure
Number of subjects: 274
Study 22800982 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite measures (BPI total, PEG, SF-36 pain)
Number of subjects: 274
Study 19397224 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant therapy (daily combination of vitamin E 800 IU, vitamin C 250 mg, vitamin B6 100 mg, vitamin B12 250 mcg, folic acid 10 mg) for 8 weeks
Number of subjects: 37
Study 19397224 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 37
Study 17963429 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperine 20mg
Number of subjects: 8
Study 17963429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 16856571 — intervention group
Group type: COMPARATOR
Intervention: Nicorandil (NCR) administered intravenously (4 mg) via intracoronary injection (2 mg) or continuously (4 mg/h) in poor flow patients.
Number of subjects: 68
Study 16856571 — intervention group
Group type: COMPARATOR
Intervention: Nicorandil (NCR) administered in good flow patients.
Number of subjects: 68
Study 12589717 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D computer animation visualization of TMJ sounds and mandibular motion
Number of subjects: 6
Study 10639305 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-limited exercise test
Number of subjects: 395
Study 10639305 — intervention group
Group type: COMPARATOR
Intervention: No exercise test
Number of subjects: 395
Study 9251423 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm P2AM single bolus dose at admission followed by placebo infusion over the next 4 days
Number of subjects: 72
Study 9251423 — intervention group
Group type: COMPARATOR
Intervention: 12 gm P2AM as a continuous infusion over the next 4 days
Number of subjects: 72
Study 9251423 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm P2AM within 12 hours of ingestion
Number of subjects: 72
Study 9251423 — intervention group
Group type: COMPARATOR
Intervention: P2AM after 12 hours of ingestion
Number of subjects: 72
Study 1531383 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal midazolam (2 mg)
Number of subjects: 28
Study 1531383 — intervention group
Group type: COMPARATOR
Intervention: Epidural methyl prednisolone (80 mg)
Number of subjects: 28
Study 6088395 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g intravenous immunoglobulin divided into three doses per therapy course for infection prophylaxis (Group A)
Number of subjects: 32
Study 6088395 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B) receiving identical chemoradiotherapy without immunoglobulin therapy
Number of subjects: 32
Study 31964402 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sectoral rehabilitation programme
Number of subjects: 118
Study 31964402 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 118
Study 30721985 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive balance training (exposures to slips and trips) - 3 sessions of 40 minutes each (total 120 minutes) over 2 days
Number of subjects: 44
Study 30721985 — intervention group
Group type: COMPARATOR
Intervention: Sham training - 1 session of 40 minutes
Number of subjects: 44
Study 28061753 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 1 g single dose
Number of subjects: 700
Study 28061753 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline 100 mg twice daily for 7 days
Number of subjects: 700
Study 28061753 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 700
Study 26010418 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (≥180 seconds after delivery)
Number of subjects: 382
Study 26010418 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (≤10 seconds after delivery)
Number of subjects: 382
Study 23328000 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1000mg daily
Number of subjects: 91
Study 23328000 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 30mg daily
Number of subjects: 91
Study 20651694 — intervention group
Group type: EXPERIMENTAL
Intervention: NIDCAP (experimental group, E=12)
Number of subjects: 30
Study 20651694 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group, C=18)
Number of subjects: 30
Study 19835676 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored educational intervention on depression using a modified version of the Prochaska stages of change model
Number of subjects: 192
Study 19835676 — intervention group
Group type: COMPARATOR
Intervention: Standard continuing medical education
Number of subjects: 192
Study 16723884 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (loading 10 mg/kg followed by 30 mg/kg daily)
Number of subjects: 104
Study 16723884 — intervention group
Group type: COMPARATOR
Intervention: Nimodipine (48 mg/d)
Number of subjects: 104
Study 16723884 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 104
Study 16723884 — intervention group
Group type: COMPARATOR
Intervention: Nimodipine
Number of subjects: 104
Study 16723884 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate and Nimodipine
Number of subjects: 104
Study 14981369 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 344
Study 14981369 — intervention group
Group type: COMPARATOR
Intervention: Colposuspension
Number of subjects: 344
Study 11758626 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes shared care
Number of subjects: 183
Study 9237086 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute laboratory challenge
Number of subjects: 0
Study 9237086 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute laboratory challenge with adjustments for hemoconcentration
Number of subjects: 0
Study 8481256 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 60
Study 8481256 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined indomethacin and thymopentin
Number of subjects: 60
Study 8481256 — intervention group
Group type: COMPARATOR
Intervention: Conventional postoperative therapy
Number of subjects: 60
Study 2942618 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation in the cervical spine
Number of subjects: 3
Study 2942618 — intervention group
Group type: COMPARATOR
Intervention: Sham maneuver with no dynamic thrust
Number of subjects: 3
Study 2942618 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 3
Study 29450866 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced medial plus lateral wall decompression (MLD)
Number of subjects: 38
Study 29450866 — intervention group
Group type: COMPARATOR
Intervention: Single lateral decompression (LD)
Number of subjects: 38
Study 29450866 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques (LD and MLD)
Number of subjects: 38
Study 28206674 — intervention group
Group type: EXPERIMENTAL
Intervention: SCS-ON (Spinal Cord Stimulation, 50 Hz, 210-μs pulse duration, 12 hours daily)
Number of subjects: 13
Study 28206674 — intervention group
Group type: COMPARATOR
Intervention: SCS-OFF (No Spinal Cord Stimulation)
Number of subjects: 13
Study 28206674 — intervention group
Group type: EXPERIMENTAL
Intervention: SCS-ON
Number of subjects: 13
Study 28206674 — intervention group
Group type: COMPARATOR
Intervention: SCS-OFF
Number of subjects: 13
Study 25898052 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin (67.5 mg)
Number of subjects: 25
Study 25898052 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin (22.5 mg)
Number of subjects: 25
Study 25898052 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin (7.5 mg)
Number of subjects: 25
Study 25898052 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin (2.5 mg)
Number of subjects: 25
Study 25898052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 25898052 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 25
Study 23460732 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization due to worsening heart failure (WHF)
Number of subjects: 6558
Study 23460732 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization due to myocardial infarction (MI)
Number of subjects: 6558
Study 23460732 — intervention group
Group type: COMPARATOR
Intervention: Not hospitalized for WHF or MI
Number of subjects: 6558
Study 23460732 — intervention group
Group type: EXPERIMENTAL
Intervention: First WHF hospitalization
Number of subjects: 6558
Study 23460732 — intervention group
Group type: EXPERIMENTAL
Intervention: First MI hospitalization
Number of subjects: 6558
Study 22007909 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% urea-based lotion (Ureadin Rx 10)
Number of subjects: 30
Study 22007909 — intervention group
Group type: COMPARATOR
Intervention: Glycerol-based emollient cream (Dexeryl)
Number of subjects: 30
Study 18226982 — intervention group
Group type: EXPERIMENTAL
Intervention: Unbanded LRYGB
Number of subjects: 60
Study 18226982 — intervention group
Group type: COMPARATOR
Intervention: Banded LRYGB
Number of subjects: 60
Study 18226982 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 16490584 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (Sensibit)
Number of subjects: 32
Study 16490584 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (Clarityne)
Number of subjects: 32
Study 12499977 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose antithrombin (AT group)
Number of subjects: 0
Study 12499977 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone (nonAT group)
Number of subjects: 0
Study 12499977 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 12499977 — intervention group
Group type: EXPERIMENTAL
Intervention: COT levels at hospital admission
Number of subjects: 0
Study 12499977 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine coagulation tests
Number of subjects: 0
Study 12499977 — intervention group
Group type: EXPERIMENTAL
Intervention: COT
Number of subjects: 0
Study 12832314 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide/metformin
Number of subjects: 192
Study 12832314 — intervention group
Group type: COMPARATOR
Intervention: Nateglinide/metformin
Number of subjects: 192
Study 11234559 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment twice daily
Number of subjects: 63
Study 11234559 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of calcipotriol and diflucortolone valerate ointment
Number of subjects: 63
Study 11234559 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (calcipotriol and diflucortolone valerate)
Number of subjects: 63
Study 11234559 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 63
Study 8672752 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phosphate (n = 61)
Number of subjects: 116
Study 8672752 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (n = 55)
Number of subjects: 116
Study 1646775 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan
Number of subjects: 11
Study 1646775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 6491703 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (15 mg/kg by rapid intravenous injection X 3) plus radiation (3,750 rad in 24 fractions)
Number of subjects: 62
Study 6491703 — intervention group
Group type: COMPARATOR
Intervention: No surgical adjuvant therapy
Number of subjects: 62
Study 6491703 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated patients
Number of subjects: 62
Study 6491703 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment refusal
Number of subjects: 62
Study 6491703 — intervention group
Group type: EXPERIMENTAL
Intervention: Local-regional component of first clinical recurrence
Number of subjects: 62
Study 30826763 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to Renewed digital intervention
Number of subjects: 0
Study 30826763 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to Renewed digital intervention with brief human support
Number of subjects: 0
Study 30826763 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 29848902 — intervention group
Group type: EXPERIMENTAL
Intervention: ipragliflozin 50 mg/day
Number of subjects: 0
Study 29848902 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 25237981 — intervention group
Group type: EXPERIMENTAL
Intervention: AAB (Theramine) alone
Number of subjects: 122
Study 25237981 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen alone
Number of subjects: 122
Study 25237981 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of AAB and ibuprofen
Number of subjects: 122
Study 24768476 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 min CWI in 6 °C
Number of subjects: 50
Study 24768476 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 min CWI in 10 °C
Number of subjects: 50
Study 24768476 — intervention group
Group type: EXPERIMENTAL
Intervention: Short intermittent CWI (1 min × 3 at 10 °C)
Number of subjects: 50
Study 24768476 — intervention group
Group type: EXPERIMENTAL
Intervention: Short contrast immersion (1 min 38 °C/1 min 10 °C × 3)
Number of subjects: 50
Study 24768476 — intervention group
Group type: COMPARATOR
Intervention: Control (seated rest)
Number of subjects: 50
Study 22455381 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared-care intervention (multidisciplinary obesity clinic appointment followed by regular GP appointments over 12 months)
Number of subjects: 0
Study 22455381 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared-care intervention
Number of subjects: 0
Study 20883560 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG-Fresenius plus reduced-dose tacrolimus monotherapy
Number of subjects: 0
Study 20883560 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose tacrolimus plus steroids
Number of subjects: 0
Study 17700333 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgery (n = 29)
Number of subjects: 56
Study 17700333 — intervention group
Group type: COMPARATOR
Intervention: Standard surgery (n = 27)
Number of subjects: 56
Study 16046455 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone administration (GH) 6 IU/day for 2 weeks
Number of subjects: 16
Study 16046455 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Plc)
Number of subjects: 16
Study 12153969 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily 2.5 mg rhDNase
Number of subjects: 48
Study 12153969 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate-day 2.5 mg rhDNase
Number of subjects: 48
Study 12153969 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily 7% HS
Number of subjects: 48
Study 12153969 — intervention group
Group type: COMPARATOR
Intervention: Comparison of daily rhDNase with alternate-day rhDNase and HS
Number of subjects: 48
Study 12153969 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in NE activity
Number of subjects: 48
Study 10915394 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 100 mg/HCTZ 25 mg
Number of subjects: 0
Study 10915394 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg/HCTZ 25 mg
Number of subjects: 0
Study 7872282 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg q.i.d.
Number of subjects: 177
Study 7872282 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg q.i.d.
Number of subjects: 177
Study 7872282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 2370014 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin 5-7.5 mg/kg/day
Number of subjects: 61
Study 2370014 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin treatment
Number of subjects: 61
Study 2370014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 2370014 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 61
Study 27370 — intervention group
Group type: EXPERIMENTAL
Intervention: Penbutolol 20 mg
Number of subjects: 12
Study 27370 — intervention group
Group type: EXPERIMENTAL
Intervention: Practolol 200 mg
Number of subjects: 12
Study 27370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 27370 — intervention group
Group type: EXPERIMENTAL
Intervention: Penbutolol and Practolol
Number of subjects: 12
Study 31332775 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-injection Erector Spinae Plane Block (ESPB)
Number of subjects: 10
Study 31332775 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-injection Costotransverse Block (MICB)
Number of subjects: 10
Study 31332775 — intervention group
Group type: COMPARATOR
Intervention: Single-injection Thoracic Paravertebral Block (TPVB)
Number of subjects: 10
Study 31332775 — intervention group
Group type: COMPARATOR
Intervention: Multiple-injection Thoracic Paravertebral Block (TPVB)
Number of subjects: 10
Study 28452195 — intervention group
Group type: EXPERIMENTAL
Intervention: Serelaxin (30 µg/kg/day)
Number of subjects: 6800
Study 28452195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6800
Study 25485803 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA 44 U (CFL: 24 U, GL: 20 U)
Number of subjects: 917
Study 25485803 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA 24 U (CFL: 24 U, GL: placebo)
Number of subjects: 917
Study 25485803 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 917
Study 24950523 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Care Extended Packages at Home (PEACH)
Number of subjects: 0
Study 24950523 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 20973811 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity home-based walking program for 12 weeks
Number of subjects: 40
Study 20973811 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise program)
Number of subjects: 40
Study 18337551 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous mesna 5 mg/kg thrice weekly before dialysis
Number of subjects: 22
Study 18337551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 17228988 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 0
Study 17228988 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 0
Study 12812248 — intervention group
Group type: COMPARATOR
Intervention: Geriatric patients (group 1)
Number of subjects: 40
Study 12812248 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger patients (group 2)
Number of subjects: 40
Study 11298071 — intervention group
Group type: EXPERIMENTAL
Intervention: Remacemide
Number of subjects: 12
Study 11298071 — intervention group
Group type: EXPERIMENTAL
Intervention: Remacemide with phenobarbitone
Number of subjects: 12
Study 11298071 — intervention group
Group type: COMPARATOR
Intervention: Phenobarbitone
Number of subjects: 12
Study 11298071 — intervention group
Group type: EXPERIMENTAL
Intervention: Desglycinyl metabolite of remacemide
Number of subjects: 12
Study 9143454 — intervention group
Group type: EXPERIMENTAL
Intervention: Best Tracer Method (BTM) for soil ingestion estimation
Number of subjects: 64
Study 9143454 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional methods for soil ingestion estimation
Number of subjects: 64
Study 9143454 — intervention group
Group type: COMPARATOR
Intervention: Adult validation study
Number of subjects: 64
Study 7912949 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-Hz stimulation once every 10 s
Number of subjects: 24
Study 7912949 — intervention group
Group type: COMPARATOR
Intervention: 2-Hz stimulation once every 20 s
Number of subjects: 24
Study 3234474 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol 2.5 mg t.d.s.
Number of subjects: 12
Study 3234474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1663423 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 40 micrograms/kg
Number of subjects: 28
Study 1663423 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 80 micrograms/kg
Number of subjects: 28
Study 1663423 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 1275213 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative haemodilution with haematocrit lowered to 24.8%
Number of subjects: 46
Study 1275213 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative haemodilution limited to haematocrit 27%
Number of subjects: 46
Study 1275213 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodilution
Number of subjects: 46
Study 1275213 — intervention group
Group type: COMPARATOR
Intervention: Comparable surgical procedures without haemodilution
Number of subjects: 46
Study 31269926 — intervention group
Group type: EXPERIMENTAL
Intervention: NAP SACC UK intervention with Health Visitor support, staff training workshops, and web-based parent support; implemented in five of six intervention nurseries.
Number of subjects: 12
Study 31269926 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 12
Study 28741272 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal injection of 11.25 mg hyperbaric bupivacaine with morphine 150 µg and fentanyl 15 µg
Number of subjects: 30
Study 28741272 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal injection of 15 mg hyperbaric bupivacaine with morphine 150 µg and fentanyl 15 µg
Number of subjects: 30
Study 26034004 — intervention group
Group type: COMPARATOR
Intervention: Baseline clinical assessment alone
Number of subjects: 2331
Study 26034004 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory data
Number of subjects: 2331
Study 26034004 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete model
Number of subjects: 2331
Study 23349254 — intervention group
Group type: EXPERIMENTAL
Intervention: Biostimine (Aloe arborescens Mill. extract), 1 ampoule once daily for 4 weeks
Number of subjects: 18
Study 23349254 — intervention group
Group type: EXPERIMENTAL
Intervention: Biostimine (Aloe arborescens Mill. extract)
Number of subjects: 18
Study 23349254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 21224829 — intervention group
Group type: EXPERIMENTAL
Intervention: Small portion size of hot meals offered in addition to existing size
Number of subjects: 308